These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Open pelvic lymph node dissection for prostate cancer: a reassessment. Campbell SC; Klein EA; Levin HS; Piedmonte MR Urology; 1995 Sep; 46(3):352-5. PubMed ID: 7544933 [TBL] [Abstract][Full Text] [Related]
17. Value of prostate-specific antigen measurements in predicting lymph node involvement in prostatic cancer. Arai Y; Yoshiki T; Yamabe H; Yoshida O Urol Int; 1990; 45(6):356-60. PubMed ID: 1705062 [TBL] [Abstract][Full Text] [Related]
18. Prediction of pelvic lymph node metastasis by the ratio of cathepsin B to stefin A in patients with prostate carcinoma. Sinha AA; Quast BJ; Wilson MJ; Fernandes ET; Reddy PK; Ewing SL; Gleason DF Cancer; 2002 Jun; 94(12):3141-9. PubMed ID: 12115346 [TBL] [Abstract][Full Text] [Related]
19. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy. Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707 [TBL] [Abstract][Full Text] [Related]